Burden of Hereditary Transthyretin Amyloidosis With Polyneuropathy in Patients Enrolled in the Phase 3 Study NEURO-TTR (P1.331)

John L. Berk(Boston University), Giampaolo Merlini(University of Pavia), Stephen B. Heitner(Brigham and Women's Hospital), Morie A. Gertz(Medical University of South Carolina), Giuseppe Vita(University of Messina), Peter D. Gorevic(Université Paris-Sud), Hartmut Schmidt(Université Paris-Sud), Jesse Kwoh(Ionis Pharmaceuticals (United States)), Márcia Waddington‐Cruz(Université Paris-Sud), Stephen G. Hughes(Ionis Pharmaceuticals (United States)), Annabel K. Wang(Université Paris-Sud), Brenda F. Baker(Ionis Pharmaceuticals (United States)), Josep M. Campistol(Universitat de Barcelona), Violaine Planté‐Bordeneuve(Université Paris-Est Créteil), Brett P. Monia(Ionis Pharmaceuticals (United States)), Fábio Barroso(Université Paris-Sud), Asia Sikora Kessler(Optum (United States)), Acary Souza Bullé Oliveira(Universidade Federal de São Paulo), Carol Whelan(The Royal Free Hospital), Thomas H. Brannagan(Columbia University), Isabel Conceição(Université Paris-Sud), Brian Drachman(Penn Presbyterian Medical Center), Spencer Guthrie(Heidelberg University), Michael Polydefkis(Université Paris-Sud), Josep Gámez(Université Paris-Sud), Morton Scheinberg(Université Paris-Sud), Edward Gane(University of Auckland), David Adams(Mount Sinai Health System), Teresa Coelho(Universidade do Porto), Elizabeth J. Ackermann(Université Paris-Sud), P. James B. Dyck(Mayo Clinic), Merrill D. Benson(Indiana University School of Medicine), Bradley McEvoy(Université Paris-Sud)

Neurology

April 10, 2018

Cited by 0

Related Papers

|New England Journal of Medicine|2019|3.6k

|New England Journal of Medicine|2018|2.9k

|New England Journal of Medicine|2018|2.8k

|Leukemia|2006|2.6k

|Cell Metabolism|2006|2.1k